| Date | Title | Description |
| 10.11.2023 | Perfuze® Announces First Stroke Patient Enrolled in the MARR... | Galway, Ireland. 2 November 2023. Perfuze, a private medical device company dedicated to developing ... |
| 10.11.2023 | Artica Therapeutics Closes €12M Seed Investment to Develop C... | Leiden, The Netherlands. 2 November, 2023. Artica Therapeutics B.V. (Artica), a biotechnology compan... |
| 10.11.2023 | Complement Therapeutics Enrols First US Participant in the N... | Munich, Germany. 9 November 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnol... |
| 10.11.2023 | Shorla Oncology Announces US Acquisition of Jylamvo, an Onco... | October 31, 2023. Cambridge, Massachusetts and London. Shorla Oncology (‘Shorla’), a US-Ireland spec... |
| 11.10.2023 | Endotronix Receives IDE Approval for the Market Expanding PR... | Naperville, Illinois, USA. 9 October, 2023. Endotronix, Inc., a digital health and medical technolog... |
| 05.10.2023 | Shorla Oncology Secures $35M Series B Funding Round to Advan... | Cambridge, Massachusetts, USA. 4 October 2023. Seroba’s portfolio company, Shorla Oncology (‘Shorla’... |
| 30.09.2023 | New expanded indication will increase home hemodialysis devi... | Beverly, Massachusetts, USA. 19 September 2023. Seroba’s portfolio company, Quanta Dialysis Technolo... |
| 19.08.2023 | Quanta™ Announces Enrollment Completion in Home Run Study. | Beverly, Massachusetts, U.S.A. 17 August 2023. Seroba’s portfolio company, Quanta Dialysis Technolog... |
| 05.08.2023 | Quanta™ Receives FDA 510(k) Clearance for Expanded Indicatio... | Beverly, Mass., USA. 3 August, 2023. Quanta Dialysis System becomes first-in-class to perform three ... |
| 05.08.2023 | Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chi... | Munich, Germany. 2 August 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnolog... |
| 30.07.2023 | Palliare announces EU CE mark approval under new Medical Dev... | Galway, Ireland and Oceanside, CA, USA. 28 July, 2023. Seroba’s portfolio company, Palliare, a leadi... |
| 15.06.2023 | Coave Therapeutics announces Positive 12-months Data from On... | Paris, France. 31 May 2023. Seroba portfolio company, Coave Therapeutics (‘Coave’), a clinical-stage... |
| 09.06.2023 | Perfuze Announces Appointment of New Chair of the Board. | Galway, Ireland. 9 June, 2023. Seroba portfolio company, Perfuze, a medical device company developin... |
| 06.06.2023 | Endotronix Extends Positive Outcomes with 12-month Data Rele... | Lisle, Illinois, USA. 22 May 2023. Seroba’s portfolio company, Endotronix, Inc., a digital health an... |
| 18.04.2023 | Complement Therapeutics Secures €72 Million in Series A Fina... | Munich, Germany. 17 April 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnolog... |
| 05.04.2023 | Endotronix Announces Enrollment Completion of PROACTIVE-HF P... | Lisle, Illinois, USA. 4 April 2023. Seroba’s portfolio company, Endotronix Inc., a digital health an... |
| 07.03.2023 | Shorla Oncology Announces U.S. FDA Approval of Nelarabine In... | Cambridge, MA, USA. March 7, 2023. Shorla Oncology (‘Shorla’), a US-Ireland pharmaceutical company, ... |
| 16.02.2023 | Perfuze Announces FDA Clearance and First U.S. Clinical Use ... | Galway, Ireland. 16 February 2023. Perfuze, a medical device company developing next-generation cath... |
| 15.02.2023 | Fusion Pharmaceuticals to Acquire Phase 2 Program for 225Ac-... | Hamilton, ON, Canada and Boston, MA, USA. 13 February 2023. Fusion Pharmaceuticals Inc. (Nasdaq: FUS... |
| 01.02.2023 | Deciphex Secures €3.9m Funding to Boost Digital Pathology an... | 25 January 2023. Dublin, Ireland. Deciphex, a leading provider of pathology software and services, a... |
| 01.02.2023 | U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EV... | 31 January 2023. Galway, Ireland and Oceanside, California, USA. Palliare, a leading developer of ad... |
| 19.12.2022 | STORM Therapeutics announces closing of USD $30M Series B fi... | 14 December, 2022. Cambridge, England. STORM Therapeutics Ltd. (STORM), the clinical biotechnology c... |
| 07.12.2022 | STORM Therapeutics doses first patient with oral METTL3 targ... | 23 November 2022, Cambridge, UK. STORM Therapeutics Ltd. (STORM), the biotechnology company discover... |
| 08.10.2022 | Endotronix Celebrates 400th Implant of Cordella™ Pulmonary A... | Lisle, Ilinois, USA. 30 September 2022. Seroba portfolio company, Endotronix, Inc., a privately-held... |
| 08.10.2022 | Sibylla Biotech Raises €23 Million Series A to Advance Prote... | Verona, Italy, 4 October, 2022. Sibylla Biotech today announced the successful close of its €23 mill... |
| 08.09.2022 | STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Execu... | Cambridge, England, 7 September 2022. Seroba portfolio company, STORM Therapeutics Ltd. (STORM), the... |
| 02.09.2022 | Fusion Pharmaceuticals Announces First Patient Dosed In Phas... | Hamilton, Ontario, Canada and Boston, USA. 29 August 2022. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN... |
| 04.08.2022 | Atlantic Therapeutics Announces the Appointment of Russell M... | Galway, Ireland and Boston, USA. 27 July 2021. Atlantic Therapeutics has announced the appointment o... |
| 23.06.2022 | Fusion Pharmaceuticals Announces FDA Clearance Of IND For FP... | Hamilton, Ontario, Canada and Boston, USA. June 23, 2022. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN)... |
| 22.06.2022 | Fusion Pharmaceuticals Presents Imaging Data From Cold Antib... | Hamilton, Ontario, Canada and Boston, USA. 14 June 2022. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN),... |
| 25.05.2022 | Endotronix Announces Positive Data from SIRONA 2 in Late-Bre... | Lisle, Illinois, USA. 23 May 2022. Endotronix, Inc., a digital health and medical technology company... |
| 13.04.2022 | Shorla Oncology Appoints Dennis Purcell as Chairman of the B... | Cambridge, Mass., USA. 29 March 2022. Shorla Oncology (‘Shorla’), an Irish specialty pharmaceutical ... |
| 27.01.2022 | Fusion Pharmaceuticals Announces Nomination Of First Targete... | Hamilton, Ontario, Canada and Boston, Massachusetts, USA. 10 January, 2022. Fusion Pharmaceuticals I... |
| 27.01.2022 | Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal T... | Lisle, Illinois, USA. 5 January 2022. Seroba portfolio company, Endotronix, Inc., a digital health a... |
| 25.11.2021 | Fusion Pharmaceuticals Appoints Mohit Rawat As President And... | Hamilton, Canada and Boston, USA. 28 September 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a c... |
| 04.06.2021 | Fusion Pharmaceuticals Enters into Agreement to Build Radiop... | Hamilton, Ontario, Canada. 3 June 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage... |
| 03.03.2021 | Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsm... | Clomel, Tipperary, Ireland. 2 March 2021. Shorla Pharma Limited (‘Shorla’), a specialty pharmaceutic... |
| - | Atlantic Therapeutics Secures FDA Approval. | Galway, Ireland. 13 November 2018. Seroba’s portfolio company, Atlantic Therapeutics, a global manuf... |
| - | Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial. | Lisle, Illinois. July 15, 2019. Endotronix, Inc., a digital health and medical technology company de... |
| - | Fusion Pharmaceuticals Announces Collaboration With AstraZen... | Hamilton, Ontario and Boston, 2 November 2020. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinica... |
| - | Quanta Raises $48 million in Series C Funding Round. | Alcester, Warwickshire, UK. 29 July 2019. Seroba’s portfolio company, Quanta Dialysis Technologies L... |
| - | Endotronix Announces Positive Data from the SIRONA First-in-... | Lisle, Illinois. November 18, 2019. Seroba’s portfolio company, Endotronix, a digital health and med... |
| - | Fusion Pharmaceuticals Appoints New Chief Medical Officer | Hamilton, Ontario. 23 March 2020. Seroba’s portfolio company, Fusion Pharmaceuticals Inc., a clinica... |
| - | Quanta Announces Collaboration with B. Braun Avitum UK Ltd | Alcester, Warwickshire, UK. 13 January 2020. Seroba’s portfolio company, Quanta Dialysis Technologie... |
| - | Fusion Pharmaceuticals Appoints Industry Veteran Christopher... | Hamilton, Canada and Boston, USA. 2 November 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a cli... |
| - | Fusion Pharmaceuticals Initiates Multi-Dose Portion of Phase... | Hamilton, Ontario and Boston. 10 December 2020. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinic... |
| - | Exelixis and STORM Therapeutics Enter into Exclusive Collabo... | California, USA and Cambridge, UK. 14 October 2021.
STORM to deliver small molecule ADAR1 clinical ... |
| - | Quanta provides compact dialysis systems to NHS to support i... | Alcester, Warwickshire, UK. 01 June 2020. Seroba’s portfolio company, Quanta Dialysis Technologies L... |
| - | Atlantic Therapeutics Announces FDA Clearance for Over-the-C... | GALWAY, Ireland. 6 February 2020. Seroba’s portfolio company, Atlantic Therapeutics, a global medica... |
| - | Quanta SC+ confirmed as safe and easy to use. | Alcester, Warwickshire, UK. 15 April 2019. Seroba’s portfolio company, Quanta Dialysis Technologies ... |
| - | First Patient Dosed in Fusion Phase I trial. | Boston, Massachusetts & Hamilton, Ontario. February 19, 2019. Seroba portfolio company, Fusion P... |
| - | Endotronix Announces Enrollment of the First Patients in the... | Lisle, Illinois. February 18, 2020. Seroba’s portfolio company, Endotronix, a digital health and med... |
| - | Fusion Pharmaceuticals Announces FDA Clearance of IND for FP... | Hamilton, Ontario and Boston, Massachusetts. July 28, 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUS... |
| - | Endotronix Raises $45M Series D Financing. | Ireland and USA. 14 Sept 2018. Endotronix, Inc., a digital health, medtech company dedicated to adva... |
| - | Atlantic Therapeutics appoints Susan Trent as new CEO, based... | Galway, Ireland. 14 July 2020. Seroba’s portfolio company, Atlantic Therapeutics, a Galway-based Med... |
| - | STORM Therapeutics selects first-in-class clinical candidate... | Cambridge, UK. 22 October 2020. Seroba’s investee company, STORM Therapeutics, the leading biotechno... |
| - | CMS Approves Coverage for PQ Bypass TORUS 2 IDE Trial | Milpitas, California. 6 January 2020. Seroba’s portfolio company, PQ Bypass Inc, a medical device co... |
| - | Novate Acquired By BTG for Up To $150m. | Dublin, Ireland. 7 Sept 2018. TG plc (LSE:BTG) (BTG) and Seroba’s portfolio company, Novate, today a... |
| - | Labcyte Sold to Beckman Coulter. | Dublin, Ireland. 30 January 2019. Seroba portfolio company, Labcyte, has been acquired by Beckman Co... |
| - | Western Development Commission invests €2m in Atlantic Thera... | Galway, IrelandAtlantic Therapeutics, the Galway-based company pioneering a non-invasive, wearable t... |
| - | PQ Bypass Receives FDA “Breakthrough Device Designation” for... | MILPITAS, California. September 2, 2020. PQ Bypass Inc, a medical device pioneer bringing new advanc... |
| - | Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D... | Hamilton, ON and Boston. April 1, 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage... |
| - | Veryan Receives PreMarket Approval. | Horsham, UK. 05 October 2018. Seroba Investee, Veryan Medical Ltd, today announced that the Company ... |
| - | Fusion Pharmaceuticals Announces Pricing of Initial Public O... | Hamilton, Ontario and Boston. 25 June 2020. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN), a clinical-s... |
| - | Doctors Perform ‘Bypass’ Without Surgery. | Little Rock, Arkansas. 2 March 2018. Seroba’s investee company, PQ Bypass was making eye-catching he... |
| - | Quanta Wins Industrial Product Design 2018. | Alcester, UK. 1 October 2018. Quanta Dialysis Technologies Ltd (“Quanta”), a medical device company ... |
| - | Fusion Announces the Appointment of Pablo J. Cagnoni, M.D. t... | Boston, Massachusetts & Hamilton, Ontario. February 6, 2020. Seroba’s portfolio company, Fusion ... |
| - | Seroba Leads $8M Series A Investment into Palliare | Galway, Ireland. 28 June 2021. Palliare, an emerging company with the vision to create a safer opera... |
| - | Prexton Acquired by Lundbeck for up to €905m. | Oss, The Netherlands & Dublin, Ireland. 16 March 2018. H. Lundbeck A/S (Lundbeck) and Seroba’s I... |
| - | Atlantic Therapeutics Raise €28M in Series B Funding. | Galway, Ireland. 7 January 2019. Atlantic Therapeutics, the medical technology company developing ga... |
| - | Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysi... | Alcester, Warwickshire, UK. 8 January 2021. Seroba’s portfolio company, Quanta Dialysis Technologies... |
| - | PQ Bypass Announces Unconditional IDE Approval from U.S. FDA... | Milpitas, California & Dublin, Ireland. October 8, 2019. PQ Bypass Announces Unconditional IDE A... |
| - | Storm Therapeutics and Evotec Leverage Indigo Platform to Pr... | Hamburg, Germany. 17 November 2020. Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0... |
| - | Novozymes acquires PrecisionBiotics Group. | Dublin, Ireland. 25 June 2020. Seroba’s portfolio company, PrecisionBiotics Group has been acquired ... |
| - | FDA Approval for Endotronix Pivotal Trial. | Dublin, Ireland and Lisle, Illinois, USA. August 1, 2019. Seroba’s portfolio company, Endotronix, In... |
| - | Otsuka Medical Devices Acquires Veryan. | Dublin, Ireland. 14 December, 2018. Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), a 1... |
| - | Quanta Successfully Completes Pilot Treatments in France. | Alcester, UK. 25 April 2018. Seroba’s investee company Quanta Dialysis Technologies Ltd (“Quanta” or... |
| - | PQ Bypass Reports Positive 12-Month Results. | Milpitas, California. 28 June 2018. Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR ... |
| - | Fusion Raises $105m in Series B Financing. | Hamilton, Ontario and Dublin, Ireland. April 2nd 2019. Seroba’s portfolio company, Fusion Pharmaceut... |
| - | Palliare announces US FDA 510(k) clearance to extend the ind... | Galway, Ireland. 15 July 2021. Seroba portfolio company, Palliare, an emerging company with the visi... |
| - | Labcyte Partners with GP-write in Large-Scale Genomic Testin... | California, USA. 17 July, 2018. Labcyte Inc., today announced an agreement with the Center for Excel... |
| - | Coave Therapeutics Closes €33 million ($39 million) Series B... | Paris, France – 21st July 2021.
• Coave Therapeutics is the new name for Horama and reflects its ne... |
| - | INNOVO® Partners with Joan Lunden and Jamie Hess on Women’s ... | New York, USA. 14 October, 2021. Women’s pelvic health brand INNOVO, an FDA-cleared medical device t... |
| - | STORM Therapeutics Presents Breakthrough Data at RNA Epigene... | Cambridge, UK. 18 September 2019. STORM Therapeutics, the biotechnology company focused on the disco... |
| - | Fusion Pharmaceuticals Announces Preliminary Safety and Dosi... | Hamilton, Ontario and Boston. June 14, 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-... |
| - | Fusion Pharmaceuticals To Expand Pipeline With Acquisition O... | Hamilton, Canada and Boston, USA. March 2, 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clini... |
| - | Seroba Invests in Storm Therapeutics. | Cambridge, UK. 20 May 2019. STORM Therapeutics (“STORM”), the drug discovery company tackling diseas... |
| - | Fusion Pharmaceuticals Announces Investment from Canada Pens... | Hamilton, Ontario & Boston, Massachusetts. January 13, 2020. Seroba’s portfolio company, Fusion ... |
| - | Fusion Pharmaceuticals Announces Clinical Collaboration with... | Hamilton, Canada and Boston, USA. May 6, 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinica... |
| - | Heidi Zak, CEO of ThirdLove, joins INNOVO® in advisory role.... | USA and Ireland. 10 November, 2020. Seroba’s portfolio company, Atlantic Therapeutics, has announced... |
| - | Endotronix Celebrates 100th Implant Of The Cordella™ Pulmona... | Galway, Ireland and Lisle, IL, USA. March 23, 2021. Endotronix, Inc., a digital health and medical t... |
| - | PQ Bypass Sold to Endologix | Dublin, Ireland. 14 April 2021. Seroba’s portfolio company, PQ Bypass Inc., a medical device pioneer... |
| - | Quanta Raises $245 Million to Accelerate Commercialization o... | Alcester, England & Beverly, Mass., USA. June 23, 2021. Quanta Dialysis Technologies Ltd (“Quant... |
| - | Endotronix Appoints Industry Veteran Dan Dearen to Board of ... | Lisle, IL, USA. 2 March 2021. Endotronix, Inc., a digital health and medical technology company dedi... |
| - | Endotronix Announces Partnership with Tyndall National Insti... | Dublin, Ireland. October 15, 2019. Seroba’s portfolio company, Endotronix Ireland Limited, a digital... |
| - | Quanta Appoints New Chief Medical Officer | Alcester, UK, 4 Jan 2019: Seroba portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or th... |
| - | FutureNeuro partners with STORM Therapeutics to explore the ... | Dublin, Ireland. 9 September 2020. FutureNeuro has announced that it has entered into partnership wi... |
| - | John S. Lipman Appointed as Quanta’s President, North Americ... | Alcester, Warwickshire, UK. 24 November 2020. Seroba’s portfolio company, Quanta Dialysis Technologi... |
| - | PQ Bypass Releases Positive 24-Month Data from the DETOUR1 C... | MILPITAS, Calif. November 12, 2020. Seroba’s portfolio company, PQ Bypass, Inc, a medical device pio... |
| - | Endotronix Closes Expanded Series D Round. | Lisle, Illinois & Dublin, Ireland. Oct 1, 2019. Seroba’s investee company, Endotronix, Inc., a d... |
